Home › Alzheimer's Disease › NCT05733520

I-CARE 2: Mobile Telehealth to Reduce Alzheimer'S-related Symptoms

I-CARE 2 RCT: Mobile Telehealth to Reduce Alzheimer'S-related Symptoms for Caregivers and Patients

Who can join

Ages 18 and older · All sexes

Caregiver Inclusion Criteria:

* Self-identified primary unpaid caregiver of a person diagnosed with ADRD (at any stage) who are:
* Receiving primary care and
* Community-dwelling;
* English literate;
* Age ≥ 18 years

Caregiver Exclusion Criteria:

* Care recipient is a permanent resident of an extended care facility (nursing home);
* Involvement in another clinical trial that would prevent or interfere with study objectives;
* Sensory or other impairment prohibiting the use of a mobile touchscreen device or other study activity (after correction)

About the study

This study is a randomized, controlled trial (RCT) to evaluate the effect of Brain CareNotes (a mobile health application) on the burden experienced by unpaid caregivers of patients with dementia and on the behavioral and psychological symptoms of dementia (BPSD) displayed by care recipients. Over 39 months, the trial will enroll 184 caregivers of community-dwelling patients diagnosed with Alzheimer's disease or a related dementia (ADRD). Caregivers will be randomized to use the Brain CareNotes app or an attention control education-only app for 12 months, with usage reminders.

What is being tested

• Brain CareNotes (behavioral)
• Dementia Guide Expert (behavioral)

Sponsor: Indiana University · Participants: 184 · Started: May 30, 2023

Contact the study team

• Miriam J Rodriguez, PhD · Phone: (812) 856-1661
• Jordan R Hill, PhD · Phone: 812-856-5032

Official record on ClinicalTrials.gov — NCT05733520

Locations in the U.S.

Conditions

• Alzheimer's Disease

From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.